logo

For the Inventor, By the Inventor

Winston-Salem, NC, United States of America

Targacept, Inc.


USPTO Granted Patents = 91



Forward Citations = 748

Loading Chart...
Loading Chart...

78 inventors (with patents filed for the assignee):

goldMedal Gary Maurice Dull (44 out of 86 patents)

silverMedal Balwinder Singh Bhatti (32 out of 43 patents)

bronzeMedal Craig Harrison Miller (30 out of 37 patents)

4.  Anatoly A Mazurov (23 out of 26 patents)

5.  Lan Miao (22 out of 24 patents)

6.  Jeffrey Daniel Schmitt (22 out of 24 patents)

7.  William Scott Caldwell (19 out of 49 patents)

8.  Merouane Bencherif (16 out of 33 patents)

9.  Julio A Munoz (14 out of 20 patents)

10.  Jared Miller Wagner (11 out of 16 patents)

11.  Peter Anthony Crooks (10 out of 96 patents)

12.  Teresa Phillips (9 out of 9 patents)

13.  Jozef Klucik (9 out of 10 patents)

14.  Srishailkumar Basawannappa Hadimani (9 out of 11 patents)

15.  John Genus (8 out of 8 patents)


Core Competencies:
Nicotinic Receptor Antagonists
Cholinergic Receptors
Arylvinylazacycloalkane Compounds
Diazabicycloalkanes
Hydroxybenzoate Salts
Pharmaceutical Compositions
Neuronal Nicotinic Acetylcholine Receptor
Combination Therapy
Therapeutic Applications
Salt Forms
Bladder Disorders

91 patents:

1. 9532974 - Nicotinic receptor non-competitive antagonists (2017-01-03),
2. 9145396 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine (2015-09-29),
3. 9107915 - Hydroxybenzoate salts of metanicotine compounds (2015-08-18),
4. 8921410 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-12-30),
5. 8901177 - Method of treating bladder disorders (2014-12-02),
6. 8901151 - Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide (2014-12-02),
7. 8859609 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-10-14),
8. 8846715 - (2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof (2014-09-30),
9. 8809397 - Nicotinic receptor non-competitive antagonists (2014-08-19),
10. 8802694 - 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands (2014-08-12),
11. 8778978 - Hydroxybenzoate salts of metanicotine compounds (2014-07-15),
12. 8703802 - Process for the preparation of aryl substituted olefinic amines (2014-04-22),
13. 8633227 - Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine (2014-01-21),
14. 8633222 - Arylvinylazacycloalkane compounds and methods of preparation and use thereof (2014-01-21),
15. 8604191 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine (2013-12-10),
Targacept, Inc. is a biopharmaceutical company that discovers and develops innovative therapeutic solutions for diseases of the central nervous system. Their focus lies in developing drugs targeting a class of receptors called nicotinic receptors, which play important roles in various CNS disorders. Targacept aims to improve the lives of patients through the discovery and advancement of effective treatments. For more information about Targacept, Inc., please visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

91 Patents

#8 in Winston-Salem, NC

#99 in North Carolina

#3,961 in US

#8,185 in the World

...
Winston-Salem, NC, United States of America

Targacept, Inc.

Forward Citations = 748

78 inventors:

goldMedal Gary Maurice Dull (44 out of 86 patents)

silverMedal Balwinder Singh Bhatti (32 out of 43 patents)

bronzeMedal Craig Harrison Miller (30 out of 37 patents)

4.  Anatoly A Mazurov (23 out of 26 patents)

5.  Lan Miao (22 out of 24 patents)

Please report any incorrect information to support@idiyas.com
Loading…